P. Ronco and H. Debiec, Pathophysiological advances in membranous nephropathy: Time for a shift in patient's care, Lancet, vol.385, 1983.

L. H. Beck, R. G. Bonegio, G. Lambeau, D. M. Beck, D. W. Powell et al., M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy, N Engl J Med, vol.361, pp.11-21, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00417718

J. M. Francis, L. H. Beck, and D. J. Salant, Membranous nephropathy: A journey from bench to bedside, Am J Kidney Dis, vol.68, pp.138-147, 2016.

P. Ruggenenti, H. Debiec, B. Ruggiero, A. Chianca, T. Pellé et al., Anti-phospholipase A2 receptor antibody titer predicts postrituximab outcome of membranous nephropathy, J Am Soc Nephrol, vol.26, pp.2545-2558, 2015.
URL : https://hal.archives-ouvertes.fr/inserm-02193793

H. Z. Qin, M. C. Zhang, W. B. Le, Q. Ren, D. C. Chen et al., Combined assessment of phospholipase A2 receptor autoantibodies and glomerular deposits in membranous nephropathy, J Am Soc Nephrol, vol.27, pp.3195-3203, 2016.

E. Hoxha, I. Thiele, G. Zahner, U. Panzer, S. Harendza et al., Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy, J Am Soc Nephrol, vol.25, pp.1357-1366, 2014.

K. Dahan, H. Debiec, E. Plaisier, M. Cachanado, A. Rousseau et al., Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up, J Am Soc Nephrol, vol.28, pp.348-358, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01490466

N. M. Tomas, L. H. Beck, C. Meyer-schwesinger, B. Seitz-polski, H. Ma et al., Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy, N Engl J Med, vol.371, pp.2277-2287, 2014.

N. M. Tomas, E. Hoxha, A. T. Reinicke, L. Fester, U. Helmchen et al., Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy, J Clin Invest, vol.126, pp.2519-2532, 2016.

L. Lin, W. M. Wang, X. X. Pan, J. Xu, C. N. Gao et al., Biomarkers to detect membranous nephropathy in Chinese patients, Oncotarget, vol.7, pp.67868-67879, 2016.

H. Debiec and P. Ronco, PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy, N Engl J Med, vol.364, pp.689-690, 2011.

E. Hoxha, L. H. Beck, T. Wiech, N. M. Tomas, C. Probst et al., An indirect immunofluorescence method facilitates detection of thrombospondin type 1 domain-containing 7A-specific antibodies in membranous nephropathy, J Am Soc Nephrol, vol.28, pp.520-531, 2017.

C. Dähnrich, L. Komorowski, C. Probst, B. Seitz-polski, V. Esnault et al., Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy, Clin Chim Acta, vol.421, pp.213-218, 2013.

T. Iwakura, N. Ohashi, A. Kato, S. Baba, and H. Yasuda, Prevalence of enhanced granular expression of thrombospondin type-1 domain-containing 7A in the glomeruli of Japanese patients with idiopathic membranous nephropathy, PLoS One, vol.10, p.138841, 2015.

C. P. Larsen, L. N. Cossey, and L. H. Beck, THSD7A staining of membranous glomerulopathy in clinical practice reveals cases with dual autoantibody positivity, Mod Pathol, vol.29, pp.421-426, 2016.

J. Radhakrishnan and D. C. Cattran, The KDIGO practice guideline on glomerulonephritis: Reading between the (guide)lines-Application to the individual patient, Kidney Int, vol.82, pp.840-856, 2012.

E. Hoxha, S. Harendza, G. Zahner, U. Panzer, O. Steinmetz et al., An immunofluorescence test for phospholipase-A 2 -receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis, Nephrol Dial Transplant, vol.26, pp.2526-2532, 2011.

X. Y. Jia, S. Y. Hu, J. L. Chen, Z. Qu, G. Liu et al., The clinical and immunological features of patients with combined antiglomerular basement membrane disease and membranous nephropathy, Kidney Int, vol.85, pp.945-952, 2014.

Z. Cui, L. J. Xie, F. J. Chen, Z. Y. Pei, L. J. Zhang et al., MHC class II risk alleles and amino acid residues in idiopathic membranous nephropathy, J Am Soc Nephrol, vol.28, pp.1651-1664, 2017.

E. Hoxha, T. Wiech, P. R. Stahl, G. Zahner, N. M. Tomas et al., A mechanism for cancer-associated membranous nephropathy, N Engl J Med, vol.374, 1995.

Q. Xie, Y. Li, J. Xue, Z. Xiong, L. Wang et al., Renal phospholipase A2 receptor in hepatitis B virus-associated membranous nephropathy, Am J Nephrol, vol.41, pp.345-353, 2015.

B. Svobodova, E. Honsova, P. Ronco, V. Tesar, and H. Debiec, Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy, Nephrol Dial Transplant, vol.28, pp.1839-1844, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00919114

B. Seitz-polski, G. Dolla, C. Payré, C. A. Girard, J. Polidori et al., Epitope spreading of autoantibody response to PLA2R associates with poor prognosis in membranous nephropathy, J Am Soc Nephrol, vol.27, pp.1517-1533, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01455661

Y. C. Ma, L. Zuo, J. H. Chen, Q. Luo, X. Q. Yu et al., Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease, J Am Soc Nephrol, vol.17, pp.2937-2944, 2006.